Kyu-Won Kim
Inventor
Stats
- 10 US patents issued
- 14 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 10 US Patents Issued
- 14 US Applications Filed
- 45 Total Citation Count
- Jul 22, 2016 Most Recent Filing
- Jul 12, 2002 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| HYPOXI CO., LTD. | 3
| 2002
|
| SNU R&DB FOUNDATION | 2
1 2 1 2 1 2 | 2007
2008 2011 2012 2013 2015 2016 |
| R&DB FOUNDATION | 2
| 2012
|
| SAMSUNG ELECTRONICS CO., LTD. | 2
4 | 2008
2010 |
| SNU RDB FOUNDATION | 1
| 2009
|
| SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION | 2
| 2010
|
| SNU R&B Foundation | 1
| 2012
|
Inventor Addresses
| Address | Duration |
|---|---|
| Anyang-si, KR | Nov 25, 10 - Jul 23, 13 |
| Pusan, KR | Jan 30, 03 - Nov 16, 04 |
| Seoul, KR | Feb 25, 10 - Aug 29, 17 |
| Suwon-si, KR | Jul 24, 08 - Apr 16, 13 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 9 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 9745280 | 2017 | Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient | 0 |
| 2016/0340,331 | 2016 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | 0 |
| 9138474 | 2015 | Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease | 1 |
| 9089554 | 2015 | Composition comprising expression or activity regulators of AKAP12 for treating central nerve system diseases | 0 |
| 2015/0183,797 | 2015 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.